Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinitis Pigmentosa Syndrome”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Not applicableStudy completedNCT04141891
What this trial is testing

Advancing Understanding of Transportation Options

Who this might be right for
Diabetic RetinopathyMacular DegenerationGlaucoma+29 more
University of Colorado, Denver 529
Not applicableApproved For MarketingNCT05183802
What this trial is testing

An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)

Who this might be right for
Bardet-Biedl Syndrome (BBS)Obesity
Rhythm Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT03746522
What this trial is testing

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity

Who this might be right for
Bardet Biedl Syndrome (BBS)Alström Syndrome (AS)
Rhythm Pharmaceuticals, Inc. 52
Not applicableLooking for participantsNCT02329210
What this trial is testing

Clinical Registry Investigating Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
Marshfield Clinic Research Foundation 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05203939
What this trial is testing

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

Who this might be right for
Retinitis PigmentosaLeber Congenital Amaurosis
Ocugen 22
Large-scale testing (Phase 3)Ended earlyNCT05176717
What this trial is testing

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
Laboratoires Thea 5
Testing effectiveness (Phase 2)Looking for participantsNCT06627179
What this trial is testing

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Who this might be right for
Retinitis Pigmentosa (RP)Usher Syndrome Type 2Deaf Blind+4 more
Laboratoires Thea 81
Not applicableUnknownNCT03990727
What this trial is testing

Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.

Who this might be right for
Retinitis PigmentosaCone DystrophyUsher Syndromes+1 more
MejoraVisionMD 17,000
Not applicableLooking for participantsNCT04461444
What this trial is testing

COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study

Who this might be right for
Bardet-Biedl SyndromeAlström Syndrome
University Hospital, Strasbourg, France 350
Not applicableUnknownNCT04820244
What this trial is testing

Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study

Who this might be right for
Usher Syndrome, Type 2ARetinitis PigmentosaUSH2A
Radboud University Medical Center 36
Early research (Phase 1)Not Yet RecruitingNCT06592131
What this trial is testing

BF844 Safety and Pharmacokinetic Study in Healthy Volunteers

Who this might be right for
Usher Syndrome Type 3
EyeXCel Pty. Ltd. 76
Large-scale testing (Phase 3)Study completedNCT04966741
What this trial is testing

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency ObesityPCSK1 Deficiency Obesity+1 more
Rhythm Pharmaceuticals, Inc. 12
Not applicableStudy completedNCT05400278
What this trial is testing

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
Oslo University Hospital 30
Not applicableLooking for participantsNCT00874783
What this trial is testing

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who this might be right for
Neurodegenerative Disorders
Hadassah Medical Organization 120
Not applicableStudy completedNCT04874909
What this trial is testing

Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)

Who this might be right for
CiliopathiesNephronophthisisSenior-Loken Syndrome+3 more
Assistance Publique - Hôpitaux de Paris 240
Not applicableLooking for participantsNCT04129021
What this trial is testing

High Resolution, High-speed Multimodal Ophthalmic Imaging

Who this might be right for
Retinitis PigmentosaMaculopathy, Age RelatedMacular Dystrophy+12 more
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 1,200
Not applicableEnded earlyNCT00004345
What this trial is testing

Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome

Who this might be right for
Usher SyndromeRetinitis Pigmentosa
National Center for Research Resources (NCRR) 100
Not applicableLooking for participantsNCT07278843
What this trial is testing

Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in MYO7A

Who this might be right for
Usher Syndrome
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 60
Large-scale testing (Phase 3)Study completedNCT05194124
What this trial is testing

Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency
Rhythm Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT05392751
What this trial is testing

Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaRetinitis Pigmentosa Syndrome
Endogena Therapeutics, Inc 14
Load More Results